NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tidetron Bioworks

Tidetron Bioworks

Private
GuangzhouHealthcare & Life Scienceshttps://tidetronpeptide.com

Last Round

Series A

Extension

Mar 14, 2022

Total Funding Raised

$100M

Company Overview

Tidetron Bioworks is a synthetic biology company that develops and operates a biomanufacturing platform for the mass production of sustainable materials for the biomedical, cosmetics, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic peptidesCDMOcontract development and manufacturing organizationbio-based chemicalssynthetic biologyfermentation technologycosmetic peptidesactive pharmaceutical ingredientsAPIstrain engineeringbiomanufacturingcustom synthesispeptide discoveryOEM manufacturingsynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tidetron Bioworks Comparables

Compare Tidetron Bioworks with similar companies based on industry and business-model similarity.

Tidetron Bioworks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bota Biosciences
76%
PolyPeptide Group
68%
Ginkgo Bioworks
64%

Tidetron Bioworks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 14, 2022
AngelMay 1, 2021
Series AMay 1, 2021

Tidetron Bioworks Investors

Notable investors and investment history

Tidetron Bioworks investors
InvestorRounds
IDG CapitalAngel, Series A, Series A Extension
ZhenFundAngel, Series A
Legend CapitalSeries A Extension

Tidetron Bioworks Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tidetron Bioworks Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tidetron Bioworks's valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Year Founded2021
Last FundingMar 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.